Navigation Links
Pancreatic cancer: Researchers find drug that reverses resistance to chemotherapy
Date:9/24/2009

Berlin, Germany: For the first time researchers have shown that by inhibiting the action of an enzyme called TAK-1, it is possible to make pancreatic cancer cells sensitive to chemotherapy, opening the way for the development of a new drug to treat the disease.

Dr Davide Melisi told Europe's largest cancer congress, ECCO 15 ESMO 34 [1], in Berlin today (Thursday 24 September) that resistance to chemotherapy was the greatest challenge to treating pancreatic cancer.

"Pancreatic cancer is an incurable malignancy, resistant to every anti-cancer treatment. Targeting TAK-1 could be a strategy to revert this resistance, increasing the efficacy of chemotherapy," said Dr Melisi, who until the start of September was a Fellow at the M.D. Anderson Center in Houston (Texas, USA); he has now moved to a staff position at the National Cancer Institute in Naples (Italy). "During the past few years we have been studying the role played by a cytokine or regulatory protein called Transforming Growth Factor beta (TGFbeta) in the development of pancreatic cancer. Recently we focused our attention on a unique enzyme activated by TGFbeta, TAK-1, as a mediator for this extreme drug resistance."

Dr Melisi and his colleagues investigated the expression of TAK-1 (TGFbeta-Activated Kinase-1) in pancreatic cell lines and developed a drug that was capable of inhibiting TAK-1. They tested the activity of the TAK-1 inhibitor on its own and in combination with the anti-cancer drugs gemcitabine, oxaliplatin and SN-38 (a metabolite of the anti-cancer drug irinotecan) in cell lines, and the activity of the TAK-1 inhibitor combined with gemcitabine against pancreatic cancer in mice.

"The use of this TAK-1 inhibitor increased the sensitivity of pancreatic cells to all three chemotherapeutic drugs. By combining it with classic anti-cancer drugs, we were able to use doses of drugs up to 70 times lower in comparison with the control to kill the same number of cance
'/>"/>

Contact: Emma Mason
wordmason@mac.com
ECCO-the European CanCer Organisation
Source:Eurekalert

1

GOOD

Page: 1 2

Related medicine news :

1. The Lustgarten Foundation Expresses Condolences as Pancreatic Cancer Claims Life of Myles Brand
2. The Lustgarten Foundation Says Patrick Swayzes Death Highlights the Need for Increased Research into Early Diagnosis and Treatment of Pancreatic Cancer
3. The Pancreatic Cancer Action Network Is Saddened by the Death of Actor Patrick Swayze
4. MicroRNAs circulating in blood show promise as biomarkers to detect pancreatic cancer
5. Pancreatic Cancer Deaths Higher for Blacks
6. Blood Test May Spot Pancreatic Cancer Early
7. Blood Flow Mismatch Seen in Pancreatic Cancers
8. Abnormal Protein May Signal Pancreatic Cancer
9. Blood Type May Boost Pancreatic Cancer Risk
10. Metformin May Lower Diabetics Odds for Pancreatic Cancer
11. Pancreatic cancer risk decreased by one anti-diabetic therapy, increased by others
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2012)... (HealthDay News) -- New research suggests that young asthma ... such as ipratropium [Atrovent] -- could be more likely ... However, the increased risk was not seen ... raises concern because of the recent interest in use ... the University of Illinois at Chicago, said in a ...
(Date:5/23/2012)... Prior treatment with inhaled corticosteroids in patients ... (CAP) is associated with a lower incidence and ... study from researchers in Spain. , A parapneumonic ... fluid that accumulates between the two pleural layers, ... arises as a result of a pneumonia, lung ...
(Date:5/22/2012)... OAK BROOK, Ill. Magnetic resonance imaging (MRI) ... to pre-surgical chemotherapy significantly earlier than possible through ... online in the journal Radiology . ... prior to surgery. Research has shown that women ... are more likely to achieve breast conservation than ...
(Date:5/22/2012)... By Carina Storrs HealthDay Reporter , , TUESDAY, ... treating obstructive sleep apnea, a common cause of snoring ... serious health hazard associated with the condition -- the ... Spain examined the number of new cases of high ... used continuous positive airway pressure therapy, or CPAP, for ...
(Date:5/22/2012)... Researchers at Barrow Neurological Institute at St. Joseph,s ... why the public perceives some magic tricks in ... military tactics, marketing and sports. , Susana Martinez-Conde, ... Stephen Macknik, PhD, of Barrow,s Laboratory of Behavioral ... magic and illusions. Their most recent original research ...
Breaking Medicine News(10 mins):Health News:Asthma Meds May Be Linked to Irregular Heartbeat 2Health News:Long-term ICS use reduces pleural effusion in patients with CAP 2Health News:Breast MRI helps predict chemotherapy's effectiveness 2Health News:Sleep Apnea 'Mask' Might Also Help the Heart 2Health News:Sleep Apnea 'Mask' Might Also Help the Heart 3Health News:Sleep Apnea 'Mask' Might Also Help the Heart 4Health News:Barrow researchers use magic for discoveries 2
... The in-depth report examining internet pharmacies and life-saving ... EAASM at the 4th Global Forum ... Washington DC., WASHINGTON, June 5 The ... today unveiled its comprehensive research report,-- The Counterfeiting ...
... as Study Lends Scientific ... Arthritis Pain, SPARTA, Mich., June 5 Consumers who ... yet hesitate,to pay the premium price functional juices often command, ... Brand,s 100%,Pure Tart Cherry juice product has been added to ...
... for the World,s Longest Indoor Stair Climb Benefiting,the Damon ... Registration for Go Vertical,Chicago 2008, the annual charitable stair ... 9 a.m. CDT Tuesday, June 10 at http://www.goverticalchicago.org ... place on the morning of,November 9th, 2008, is limited ...
... Cornerstone Events of National Health IT Week, June ... through IT, WASHINGTON, June 5 The ... Information and Management,Systems Society:, (Logo: http://www.newscom.com/cgi-bin/prnh/20060801/CGTU009LOGO-a ... http://www.himsssummit.org/ ) will be held June 9-10,2008. ...
... Institution,s Department of Embryology, has been awarded the 2008 ... in recognition of his contributions to fruit fly genomics ... reproduction." The prize, which consists of a gold ... the International Congress of Genetics in Berlin on July ...
... Society, AKRON, Ohio, June 5 In an ... LLC (VHT) is proud to participate in,the American Cancer ... at Copley High School., (Logo: http://www.newscom.com/cgi-bin/prnh/20070619/CLTU033LOGO ... are expected to diagnose,more than 1.3 million new cancer ...
Other Medicine News:Health News:Death on the Net? Over 60% of Medicines Sold by Online Pharmacies are Fake 2Health News:Death on the Net? Over 60% of Medicines Sold by Online Pharmacies are Fake 3Health News:Reported Health Benefits of Tart Cherry Boosts Juice Distribution in Southern U.S. 2Health News:Go Vertical Chicago 2008 Sears Tower Stair Climb Registration Opens June 10 2Health News:Go Vertical Chicago 2008 Sears Tower Stair Climb Registration Opens June 10 3Health News:HIMSS Summit08 and Advocacy Day 2Health News:2008 Gruber Genetics Prize awarded to Allan Spradling of Carnegie Institution 2Health News:Virtual Hold Technology to Support Relay for Life of Westside 2
(Date:5/23/2012)... 2012  Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical ... for its U.S. phase 2 clinical trial, T ... G reater E fficacy T rial ... in patients with non-tuberculous mycobacterial (NTM) lung disease. ... to support current NTM treatment recommendations, and no new ...
(Date:5/23/2012)... Calif., May 23 2012  Isis Pharmaceuticals, Inc. ... webcast:What:Data from KYNAMRO™ presented at EAS 2012When:Friday, June ... PTWhere:www.isispharm.comHow:Live on the Internet.  Simply log onto our ... to participate during the live event, a replay ... limited time at www.isispharm.com . ...
(Date:5/23/2012)... 2012 Reportlinker.com announces that a new ... The Medical Device Market: ... Summary Espicom,s in-depth medical ... to understand the key drivers in medical markets ... data. Each report opens with an outlook section ...
Breaking Medicine Technology:Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease 2Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease 3Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease 4Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease 5The Medical Device Market: USA 2The Medical Device Market: USA 3The Medical Device Market: USA 4The Medical Device Market: USA 5The Medical Device Market: USA 6The Medical Device Market: USA 7The Medical Device Market: USA 8Micromet to Present at the UBS Global Life Sciences Conference on September 22 2009 14100 1Micromet to Present at the UBS Global Life Sciences Conference on September 22 2009 14100 2Micromet to Present at the UBS Global Life Sciences Conference on September 22 2009 14100 3Hard to Treat Diseases Inc 28HTDS 29 Attorney Brad Essman Uncovers Reports of Retail Brokers Making False Statements 57385 1Hard to Treat Diseases Inc 28HTDS 29 Attorney Brad Essman Uncovers Reports of Retail Brokers Making False Statements 57385 2Hard to Treat Diseases Inc 28HTDS 29 Attorney Brad Essman Uncovers Reports of Retail Brokers Making False Statements 57385 3Hard to Treat Diseases Inc 28HTDS 29 Attorney Brad Essman Uncovers Reports of Retail Brokers Making False Statements 57385 4Internet Can Help Curb Drinking Among College Students 57382 1Internet Can Help Curb Drinking Among College Students 57382 2
... Efficacy Results Support Follow-on NEST-3 TrialCARLSBAD, Calif., Feb. ... PhotoThera, Inc., transcranial laser therapy (TLT) for acute ... demonstrated improved outcomes for patients, but did not ... analysis in patients who had moderate to moderately ...
... Bulletin Board: GOVX), an Atlanta-based, publicly traded,biopharmaceutical company ... Immunodeficiency Virus) and other infectious agents, announced,the first ... Trial for its,candidate HIV/AIDS vaccine. The trial, ... Vaccine Trials Network (HVTN). The HVTN, funded ...
Other Medicine Technology:Results of NeuroThera Effectiveness and Safety Trial - 2 (NEST-2) Presented at International Stroke Conference 2009 2GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA 2GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA 3GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA 4GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA 5
... onlays are pre-cut and pre-shaped to facilitate ... more frequently done. These pre-shaped onlays are ... Ultra and are designed for use in ... both small and large sizes, they provide ...
... and soft tissue reconstructions, and in ... is sometimes necessary to encourage host ... minimizing tissue attachment along another surface.,GORE ... ePTFE sheet material that offers a ...
... is pleased to announce the latest advancement ... E/X mesh.,When Bard Composix mesh was introduced ... hernia repair prosthesis that combined two clinically ... in one product. Bard Composix E/X mesh, ...
... introduction in 1958, Bard mesh has become ... are compared. Bard mesh was used by ... the "tension-free" hernia repair many years ago. ... and ideal" substance for permanent reinforcement of ...
Medicine Products: